Further genetic hallmarks of PDAC include frequent inactivation of tumor-suppressor genes such as CDKN2A, DPC4, and TP53. Importantly, PDAC is marked by a robust desmoplastic response with the stromal compartment comprising up to 90% of the bulk tumor [3]. This evidence concerns the gene CDKN2A and neoplasm.